Radioiodine Treatment

What is radioiodine treatment?

Radioiodine treatment is a form of internal radiation therapy that uses a radioactive form of iodine, usually called iodine-131 or I-131, to destroy overactive or cancerous thyroid tissue. The thyroid is a small, butterfly-shaped gland at the front of the neck that makes hormones controlling how fast the body uses energy. It is one of the few tissues in the body that actively takes up iodine, because iodine is a building block of thyroid hormone. When a patient swallows radioactive iodine, the thyroid cells absorb it in the same way they absorb ordinary iodine from food. The radiation then damages those cells from the inside, while most other tissues receive only a small dose.

Radioiodine treatment is mainly used for two groups of conditions:

• Hyperthyroidism (an overactive thyroid), including Graves' disease (an autoimmune condition in which the immune system stimulates the whole gland), toxic multinodular goiter (an enlarged gland with several overactive lumps), and a single overactive nodule, sometimes called a toxic adenoma.
• Differentiated thyroid cancer, meaning papillary and follicular types, which usually retain the ability to take up iodine. Here, radioiodine is typically given after surgery to remove any remaining thyroid tissue and to treat cancer cells that may have spread.

It is occasionally used to shrink a large non-toxic goiter when surgery is not an option. The treatment is planned and delivered by a Nuclear Medicine department, usually working closely with endocrinologists (hormone specialists) and, for cancer, with thyroid surgeons. At Acibadem, radioiodine treatment is managed through the nuclear medicine unit in this way.

Who needs radioiodine treatment: candidates and when it is not suitable

Your doctor may consider radioiodine treatment in situations such as the following:

• Graves' disease that has come back after a course of antithyroid tablets, or when tablets cause side effects or are not controlling hormone levels.
• Toxic multinodular goiter or a toxic nodule, where medicines alone rarely provide a lasting cure.
• Papillary or follicular thyroid cancer after removal of the thyroid, particularly when the tumor is larger, has grown beyond the gland, or has reached lymph nodes or other sites.
• Thyroid cancer that has returned or spread and still takes up iodine on scans.
• Patients who prefer to avoid surgery or for whom an operation carries higher risk.

Radioiodine treatment is not suitable in some circumstances:

• Pregnancy: radioactive iodine can cross to the unborn baby and permanently damage its thyroid. A pregnancy test is routinely required beforehand in women who could become pregnant.
• Breastfeeding: the radioactive iodine passes into breast milk. Breastfeeding usually has to stop well before treatment and is not restarted for that child.
• Moderate to severe active thyroid eye disease in Graves' disease, because radioiodine may make eye symptoms worse. In milder cases, doctors sometimes give steroid tablets alongside treatment to reduce this risk.
• Thyroid cancers that do not take up iodine, such as medullary or anaplastic thyroid cancer, and some poorly differentiated tumors.
• People who cannot follow radiation safety precautions at home, for example because they are the sole caregiver of very young children and no alternative arrangements can be made.

The decision is individual. In many cases, doctors weigh radioiodine against long-term antithyroid medicine and surgery, and the right choice depends on the cause of the thyroid problem, its severity, age, other health conditions, and personal preferences.

How the radioiodine treatment procedure works

Although it involves radiation, the radioiodine treatment procedure itself is simple from the patient's point of view. There is no surgery and no anesthesia (medicine to make you sleep or numb an area).

Before treatment

• Blood tests measure thyroid hormone levels and, for cancer, a protein called thyroglobulin, which is used later to monitor the response.
• A small test dose of radioactive iodine, or a related tracer, may be given first so that a scan can show how much iodine the thyroid tissue absorbs. This helps the team choose the dose.
• The activity (amount of radioactivity) is selected based on the condition. Doses for hyperthyroidism are generally much lower than doses used for thyroid cancer.

During treatment

• You swallow one or more capsules, or occasionally a liquid, in a designated room in the nuclear medicine department. Staff handle the material with shielding and follow strict safety procedures.
• Swallowing the dose takes only a few minutes. Most patients feel nothing at the time.
• For lower doses, typically used in hyperthyroidism, you usually go home the same day. For higher cancer doses, many hospitals admit patients to a shielded single room for one to several nights until the radiation they give off falls below a set level.

After treatment

• The radioactive iodine that is not absorbed by thyroid tissue leaves the body mainly in urine over the following days, and in smaller amounts in saliva and sweat.
• For thyroid cancer, a whole-body scan is often performed a few days to a week later to show where the iodine has gone, which can reveal remaining thyroid tissue or areas of spread.
• Follow-up blood tests over the following weeks and months show whether the treatment is having the intended effect.

Preparation for radioiodine treatment

Careful preparation matters because the treatment only works well if the thyroid cells are "hungry" for iodine. Your team will give specific instructions, which commonly include:

• Low-iodine diet: for one to two weeks before treatment, many centers ask patients to limit iodized salt, seafood, seaweed, dairy products, egg yolks, and processed foods containing iodine, so that the radioactive iodine is taken up more effectively.
• Avoiding iodine-containing medicines and contrast: CT scans with iodine contrast dye, certain cough medicines, and some supplements can saturate the thyroid with ordinary iodine. Treatment is usually delayed for several weeks after such exposure.
• Stopping antithyroid tablets: medicines such as methimazole, carbimazole, or propylthiouracil are usually paused for several days beforehand because they can reduce the effect of radioiodine. Do not stop them without instruction.
• Raising TSH for cancer treatment: TSH (thyroid-stimulating hormone) is the pituitary hormone that tells thyroid cells to take up iodine. Before cancer treatment, TSH is raised either by stopping thyroid hormone replacement tablets for a few weeks, which causes temporary symptoms of an underactive thyroid, or by two injections of recombinant TSH, which avoids that withdrawal.
• Pregnancy testing and contraception: a negative pregnancy test is required shortly before treatment for women who could be pregnant, and reliable contraception is advised for both men and women for a period afterward as set by the treating team.
• Planning home precautions: arranging sleeping space, time off work, and childcare in advance makes the restriction period after treatment easier.

Recovery and aftercare: radioiodine treatment recovery time

Recovery from radioiodine treatment is different from recovery after an operation. There is no wound to heal, and most people feel physically much as they did before. The main elements are radiation safety precautions and waiting for the treatment to take effect.

Radiation precautions typically last from a few days to about two weeks, depending on the dose. Common advice includes:

• Keeping a distance of roughly an arm's length or more from other people, and limiting close contact time, especially with children and pregnant women.
• Sleeping alone and avoiding kissing or sexual contact for the period advised.
• Drinking plenty of fluids and urinating often to clear iodine from the body; sitting to urinate, flushing twice, and washing hands thoroughly.
• Using separate towels, cutlery, and dishes, or washing them separately, for the first days.
• Sucking sour candies or chewing gum after higher doses, if the team recommends it, to stimulate saliva flow and reduce salivary gland irritation.
• Carrying a letter from the hospital when traveling, because radiation detectors at airports and borders may register the treatment for several weeks.

Return to activity: many patients return to work and normal routines once the precaution period ends, often within one to two weeks. People who work closely with children or pregnant colleagues may be advised to stay away longer.

Waiting for the effect: radioiodine acts slowly. In hyperthyroidism, hormone levels typically start to fall over several weeks, and the full effect is usually judged at around three to six months. Some patients feel a temporary flare of overactive symptoms in the first weeks. For thyroid cancer, the destruction of remaining tissue is assessed through blood tests and scans over the following months.

Ongoing monitoring: regular blood tests are essential, because most people treated for hyperthyroidism, and all those whose thyroid has been removed for cancer, eventually need daily thyroid hormone replacement tablets. Doses are adjusted based on test results.

Radioiodine treatment risks and benefits: side effects to expect

Understanding radioiodine treatment risks and benefits helps set realistic expectations. The main benefit is that a single dose can often bring lasting control of hyperthyroidism or eliminate remaining thyroid cancer cells without surgery. The risks are generally modest but real.

Short-term side effects may include:

• Mild neck tenderness or swelling for a few days, sometimes called radiation thyroiditis.
• Nausea, usually mild and short-lived, more common with higher doses.
• Dry mouth, altered taste, or swelling and soreness of the salivary glands, which can occasionally persist.
• Temporary worsening of overactive thyroid symptoms as damaged cells release stored hormone.
• Fatigue, particularly in cancer patients who stopped hormone tablets before treatment.

Longer-term considerations:

• Hypothyroidism (an underactive thyroid) is the most common lasting outcome after treatment for hyperthyroidism and is expected after cancer treatment. It is managed with daily levothyroxine tablets, which replace the missing hormone.
• Thyroid eye disease may appear or worsen in some people with Graves' disease, particularly smokers.
• Fertility and pregnancy: fertility is not thought to be permanently affected at usual doses, but pregnancy is generally advised against for at least six months and often longer after treatment. Men may be advised to wait several months before fathering a child, and sperm banking may be discussed before repeated high doses.
• Second cancers: a small increase in the risk of other cancers has been reported mainly with high cumulative doses used for thyroid cancer. The absolute risk is considered low, and doctors weigh it against the benefit of treating the cancer.
• Bone marrow effects: temporary reductions in blood cell counts can occur after very high or repeated doses.

Results and outlook

For hyperthyroidism, radioiodine is widely regarded as an effective and long-established treatment. A single dose brings the overactive thyroid under control in most patients, though a minority need a second dose. The trade-off is that many patients become hypothyroid and require lifelong hormone replacement, which is usually straightforward to manage with regular blood tests.

For differentiated thyroid cancer, the outlook is generally favorable, particularly for smaller tumors confined to the neck. Radioiodine after surgery is intended to lower the chance of recurrence and to make later monitoring more reliable, since remaining thyroid tissue is removed and the thyroglobulin blood test becomes a more sensitive marker. Not every patient with thyroid cancer needs radioiodine; for very low-risk tumors, current practice increasingly favors surgery alone with careful observation. When cancer has spread, radioiodine can still be effective, although some tumors lose the ability to absorb iodine over time and then require other approaches.

Outcomes vary from person to person, and your specialist can explain how the evidence applies to your specific situation.

Cost considerations

The overall cost of radioiodine treatment depends on several factors rather than on the capsule alone. These commonly include:

• The dose and purpose of treatment, because cancer doses often require an inpatient stay in a specially shielded room, while low-dose hyperthyroidism treatment is usually outpatient.
• The length of any hospital stay, which depends on how quickly radiation levels fall to the threshold set by local regulations.
• Preparatory tests and scans, such as thyroid uptake studies, blood tests, and pregnancy testing.
• Whether recombinant TSH injections are used instead of hormone withdrawal before cancer treatment.
• Follow-up imaging, including the post-treatment whole-body scan and later scans.
• Long-term monitoring and hormone replacement medication, which continues for years.

Insurance coverage and hospital pricing structures differ, so the treating center can provide an itemized estimate for the specific plan.

Frequently asked questions

Who needs radioiodine treatment rather than tablets or surgery?

Radioiodine is often considered when antithyroid tablets have not produced a lasting remission, cause side effects, or when the cause is a toxic nodule or multinodular goiter that rarely settles with medicine alone. It is also standard after surgery for many intermediate- and higher-risk differentiated thyroid cancers. Surgery may be preferred when the goiter is very large, when there is pressure on the windpipe, or when eye disease is active. The choice is individual and made together with your specialist.

How long does the radioiodine treatment procedure take?

Swallowing the dose takes only a few minutes, though the visit itself, including checks and safety instructions, may last an hour or two. For higher cancer doses, an inpatient stay of one to several nights in a shielded room is common until radiation levels fall to the required level. Preparation, including a low-iodine diet and hormone adjustments, usually spans one to several weeks beforehand.

What is the typical radioiodine treatment recovery time?

Most people feel physically well and can resume light daily activities immediately, but radiation precautions typically limit close contact with others for a few days to about two weeks, depending on the dose. Many patients return to work within one to two weeks. The therapeutic effect on the thyroid develops more slowly, often over weeks to months, and is tracked with blood tests.

Is radioiodine treatment safe for the people around me?

The dose received by family members is small when the recommended precautions are followed, such as keeping distance, sleeping apart, and good bathroom hygiene for the advised period. The precautions exist mainly to protect children and pregnant women, whose developing thyroids are more sensitive. Your team will give written guidance tailored to the dose you receive.

Will I definitely need thyroid hormone tablets afterward?

After treatment for thyroid cancer, yes, because the thyroid has been removed and its remaining tissue destroyed. After treatment for hyperthyroidism, many patients eventually become underactive and need replacement, though the timing varies from months to years. Some people with a single toxic nodule retain enough normal thyroid to avoid tablets. Regular blood tests are the only reliable way to know.

Can I have children after radioiodine treatment?

Fertility is not generally thought to be permanently reduced at usual doses, but pregnancy is advised against for at least six months and often longer, both to allow radiation to clear and to ensure thyroid hormone levels are stable, which matters for a healthy pregnancy. Men are also typically advised to wait several months. Discuss timing and any plans for repeated doses with your doctor beforehand.

What are the main radioiodine treatment risks and benefits compared with surgery?

Radioiodine avoids an operation, anesthesia, a neck scar, and surgical risks to the voice nerves and calcium-regulating glands, and it can be repeated if needed. Its drawbacks include a slower onset, temporary radiation precautions, possible salivary gland effects, a potential worsening of Graves' eye disease, and the near-certainty of needing hormone replacement. Surgery works faster and is sometimes preferred for very large goiters or when radiation is unsuitable.

When to see a doctor

You should be assessed by an endocrinologist or nuclear medicine specialist if you have been told your thyroid is overactive and treatment options are being considered, if hyperthyroidism has returned after a course of tablets, or if you have been diagnosed with thyroid cancer and need to discuss whether radioiodine is appropriate after surgery. Symptoms such as unexplained weight loss, a racing or irregular heartbeat, tremor, heat intolerance, or a new lump in the neck also warrant medical review, although they have many possible causes and do not by themselves mean radioiodine is needed.

After radioiodine treatment, contact your treating team promptly if you notice:

• Severe or worsening neck pain or swelling that makes swallowing or breathing difficult.
• A very fast heartbeat, palpitations, chest pain, high fever, confusion, or agitation, which can be signs of a rare but serious surge of thyroid hormone called thyroid storm and require urgent emergency care.
• New or worsening eye symptoms such as bulging, double vision, pain, or reduced vision.
• Persistent vomiting that prevents you from keeping fluids down.
• Extreme tiredness, feeling very cold, marked weight gain, or a slow heartbeat in the months afterward, which may indicate an underactive thyroid needing dose adjustment.
• A positive pregnancy test within the period during which pregnancy was advised against.

Routine follow-up appointments and blood tests should be kept even if you feel well, because thyroid hormone changes after radioiodine can develop gradually and without obvious symptoms.